Literature DB >> 4084337

Gabapentin decreases monoamine release without affecting acetylcholine release in the brain.

E Schlicker, W Reimann, M Göthert.   

Abstract

Superfused rat brain cortex slices preincubated with 3H-noradrenaline or 3H-serotonin and superfused rabbit caudate nucleus slices preincubated with 3H-choline were used to examine the effects of gabapentin (an amino acid chemically related to gamma-aminobutyric acid, GABA) on the electrically evoked 3H overflow. Gabapentin inhibited the electrically (3 Hz) evoked 3H overflow from slices preincubated with the 3H-monoamines in a concentration-dependent manner (at 1 mmol/l by 20-30%), but did not affect the evoked overflow from slices preincubated with 3H-choline. The following drugs did not modify the inhibitory effects of gabapentin: bicuculline, RS-baclofen, GABA, phentolamine, metitepin, cocaine, and the inhibitor of serotonin uptake, 6-nitroquipazine. Gabapentin did not modify the inhibitory effect of GABA on the evoked 3H overflow from slices preincubated with 3H-serotonin. In slices preincubated with 3H-noradrenaline the inhibitory effect of gabapentin was still observed when the stimulation frequency was 10 instead of 3 Hz. In conclusion, gabapentin mimics GABAB receptor activation, but it appears to act by a GABA receptor-independent, as yet unidentified mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4084337

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  10 in total

1.  Structural requirement of the calcium-channel subunit alpha2delta for gabapentin binding.

Authors:  M Wang; J Offord; D L Oxender; T Z Su
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat.

Authors:  Serena Stopponi; Lorenzo Somaini; Andrea Cippitelli; Giordano de Guglielmo; Marsida Kallupi; Nazzareno Cannella; Gilberto Gerra; Maurizio Massi; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2011-09-02       Impact factor: 4.530

3.  Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices.

Authors:  K Fink; W Meder; D J Dooley; M Göthert
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 4.  Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.

Authors:  Karen L Goa; Eugene M Sorkin
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

5.  Differential modulation of K(+)-evoked (3)H-neurotransmitter release from human neocortex by gabapentin and pregabalin.

Authors:  B Brawek; M Löffler; D J Dooley; A Weyerbrock; T J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-12       Impact factor: 3.000

6.  Gabapentin augments whole blood serotonin in healthy young men.

Authors:  M L Rao; P Clarenbach; M Vahlensieck; S Krätzschmar
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

7.  Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome.

Authors:  Jeremy D Gale; Lesley A Houghton
Journal:  Front Pharmacol       Date:  2011-06-09       Impact factor: 5.810

Review 8.  Review about gabapentin misuse, interactions, contraindications and side effects.

Authors:  Gabriel C Quintero
Journal:  J Exp Pharmacol       Date:  2017-02-09

Review 9.  Gabapentin in acute postoperative pain management.

Authors:  Connie Y Chang; Chaitanya K Challa; Janki Shah; Jean Daniel Eloy
Journal:  Biomed Res Int       Date:  2014-04-14       Impact factor: 3.411

Review 10.  The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism.

Authors:  Hueng-Chuen Fan; Herng-Shen Lee; Kai-Ping Chang; Yi-Yen Lee; Hsin-Chuan Lai; Pi-Lien Hung; Hsiu-Fen Lee; Ching-Shiang Chi
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.